FR7337M
(xx)
*
|
1968-01-11 |
1969-10-13 |
|
|
FR2096868B1
(xx)
*
|
1970-07-08 |
1974-02-01 |
Roussel Uclaf |
|
GB1318300A
(en)
*
|
1970-12-09 |
1973-05-23 |
Labaz |
Indole derivatives nad compositions containing the same
|
GB1436771A
(en)
*
|
1973-02-16 |
1976-05-26 |
Labaz |
Indole derivatives and process for preparing the same
|
US4021448A
(en)
*
|
1975-10-21 |
1977-05-03 |
Sterling Drug Inc. |
2-Substituted-indole-1-lower-alkanecarboxamides
|
SE421917B
(sv)
*
|
1976-01-21 |
1982-02-08 |
Roussel Uclaf |
Analogiforfarande for framstellning av nya derivat av 2-metyl-1-indolyl-ettikssyra med terapeutisk verkan
|
US4233312A
(en)
*
|
1976-01-21 |
1980-11-11 |
Roussel Uclaf |
Esters of indole-1-acetic acid and analgesic use thereof
|
US4460777A
(en)
*
|
1981-11-19 |
1984-07-17 |
Ciba-Geigy Corporation |
N-Substituted-2-pyridylindoles
|
US4478842A
(en)
*
|
1981-11-19 |
1984-10-23 |
Ciba-Geigy Corporation |
N-Substituted-2-pyridylindoles
|
US4511573A
(en)
*
|
1983-05-17 |
1985-04-16 |
Ciba-Geigy Corporation |
3-Substituted-2-(heteroaryl) indoles
|
US5137910A
(en)
*
|
1989-05-05 |
1992-08-11 |
C.D. Searle & Co. |
Compositions containing indole-2-carboxylate compounds for treatment of CNS disorders
|
US5229413A
(en)
*
|
1989-05-05 |
1993-07-20 |
G. D. Searle & Co. |
Compositions containing indole-2-carboxylate compounds for treatment of CNS disorders
|
EP0603278A1
(en)
*
|
1991-09-11 |
1994-06-29 |
Fujisawa Pharmaceutical Co., Ltd. |
Indole derivatives as 5-alpha-reductase inhibitor
|
GB9204024D0
(en)
*
|
1992-02-25 |
1992-04-08 |
Fujisawa Pharmaceutical Co |
Indole derivatives
|
GB9204365D0
(en)
*
|
1992-02-28 |
1992-04-08 |
Pfizer Ltd |
Indoles
|
ES2099007B1
(es)
*
|
1993-07-16 |
1997-12-01 |
Pfizer Res & Dev |
Derivados de indol.
|
GB9716657D0
(en)
*
|
1997-08-07 |
1997-10-15 |
Zeneca Ltd |
Chemical compounds
|
GB9803226D0
(en)
*
|
1998-02-17 |
1998-04-08 |
Zeneca Ltd |
Chemical compounds
|
YU59600A
(sh)
*
|
1998-03-31 |
2002-12-10 |
The Institute For Pharmaceutical Discovery Inc. |
Supstituisane indolalkanoidske kiseline
|
TNSN99224A1
(fr)
|
1998-12-01 |
2005-11-10 |
Inst For Pharm Discovery Inc |
Methodes de reduction des niveaux de glucose et triglyceride en serum et pour suppression de l'antigenese utilisant les acides la indolealkanoique
|
GB9902461D0
(en)
|
1999-02-05 |
1999-03-24 |
Zeneca Ltd |
Chemical compounds
|
GB9902459D0
(en)
|
1999-02-05 |
1999-03-24 |
Zeneca Ltd |
Chemical compounds
|
GB9902455D0
(en)
|
1999-02-05 |
1999-03-24 |
Zeneca Ltd |
Chemical compounds
|
GB9902452D0
(en)
|
1999-02-05 |
1999-03-24 |
Zeneca Ltd |
Chemical compounds
|
GB9902453D0
(en)
|
1999-02-05 |
1999-03-24 |
Zeneca Ltd |
Chemical compounds
|
KR20080015482A
(ko)
*
|
1999-02-10 |
2008-02-19 |
아스트라제네카 아베 |
혈관형성 억제제로서의 퀴나졸린 유도체
|
GB0000625D0
(en)
|
2000-01-13 |
2000-03-01 |
Zeneca Ltd |
Chemical compounds
|
TWI224101B
(en)
*
|
2001-06-20 |
2004-11-21 |
Wyeth Corp |
Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
|
JP4399253B2
(ja)
*
|
2001-06-20 |
2010-01-13 |
ワイス |
プラスミノゲンアクチベーターインヒビター−1(pai−1)のインヒビターとしての、置換されたインドール酸誘導体
|
TWI317634B
(en)
*
|
2001-12-13 |
2009-12-01 |
Nat Health Research Institutes |
Aroyl indoles compounds
|
US7528165B2
(en)
*
|
2001-12-13 |
2009-05-05 |
National Health Research Institutes |
Indole compounds
|
US7632955B2
(en)
*
|
2001-12-13 |
2009-12-15 |
National Health Research Institutes |
Indole compounds
|
AU2003239972B2
(en)
*
|
2002-06-14 |
2008-02-28 |
Merck & Co., Inc. |
Ophthalmic compositions for treating ocular hypertension
|
MXPA05001011A
(es)
*
|
2002-07-26 |
2005-06-08 |
Inst For Pharm Discovery Inc |
Derivado de acidos indolalcanoicos substituidos y formulaciones que lo contienen para uso en tratamiento de complicaciones diabeticas.
|
ATE331709T1
(de)
*
|
2002-12-10 |
2006-07-15 |
Wyeth Corp |
Substituierte 3-carbonyl-1-yl essigsäure derivate als plasminogen aktivator inhibitor(pai-1) inhibitoren
|
EP1569901B1
(en)
*
|
2002-12-10 |
2008-10-15 |
Wyeth |
ARYL, ARYLOXY, AND ALKYLOXY SUBSTITUTED i 1H /i -INDOL-3-YL GLYOXYLIC ACID DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1)
|
DE60306547T2
(de)
*
|
2002-12-10 |
2007-06-28 |
Wyeth |
Substituierte 3-alkyl- und 3-arylalkyl-1h-indol-1-yl-essigsäure-derivate als plasminogen-aktivator
|
UA80453C2
(en)
*
|
2002-12-10 |
2007-09-25 |
|
Derivatives of substituted dyhydropyranoindol-3,4-dion as inhibitors of plasminogen activator inhibitor-1 (pai-1)
|
US7056943B2
(en)
*
|
2002-12-10 |
2006-06-06 |
Wyeth |
Substituted indole oxo-acetyl amino acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
|
DE60336646D1
(de)
*
|
2003-08-07 |
2011-05-19 |
Nat Health Research Institutes |
Indol-Verbindungen als Inhibitoren der Tubulin-Polymerisation zur Behandlung von angiogenesisbezogenen Erkrankungen
|
US7141592B2
(en)
*
|
2003-09-25 |
2006-11-28 |
Wyeth |
Substituted oxadiazolidinediones
|
US7442805B2
(en)
*
|
2003-09-25 |
2008-10-28 |
Wyeth |
Substituted sulfonamide-indoles
|
US7534894B2
(en)
|
2003-09-25 |
2009-05-19 |
Wyeth |
Biphenyloxy-acids
|
US7268159B2
(en)
*
|
2003-09-25 |
2007-09-11 |
Wyeth |
Substituted indoles
|
US7446201B2
(en)
*
|
2003-09-25 |
2008-11-04 |
Wyeth |
Substituted heteroaryl benzofuran acids
|
US7420083B2
(en)
*
|
2003-09-25 |
2008-09-02 |
Wyeth |
Substituted aryloximes
|
US7351726B2
(en)
*
|
2003-09-25 |
2008-04-01 |
Wyeth |
Substituted oxadiazolidinediones
|
US7342039B2
(en)
*
|
2003-09-25 |
2008-03-11 |
Wyeth |
Substituted indole oximes
|
US7582773B2
(en)
*
|
2003-09-25 |
2009-09-01 |
Wyeth |
Substituted phenyl indoles
|
US7163954B2
(en)
*
|
2003-09-25 |
2007-01-16 |
Wyeth |
Substituted naphthyl benzothiophene acids
|
US7332521B2
(en)
*
|
2003-09-25 |
2008-02-19 |
Wyeth |
Substituted indoles
|
US7411083B2
(en)
|
2003-09-25 |
2008-08-12 |
Wyeth |
Substituted acetic acid derivatives
|
US7265148B2
(en)
*
|
2003-09-25 |
2007-09-04 |
Wyeth |
Substituted pyrrole-indoles
|
GB0324763D0
(en)
*
|
2003-10-23 |
2003-11-26 |
Oxagen Ltd |
Use of compounds in therapy
|
CA2577782A1
(en)
*
|
2004-08-23 |
2006-03-02 |
Wyeth |
Pyrrolo-naphthyl acids as pai-1 inhibitors
|
US7605172B2
(en)
|
2004-08-23 |
2009-10-20 |
Wyeth |
Thiazolo-naphthyl acids
|
US7754747B2
(en)
*
|
2004-08-23 |
2010-07-13 |
Wyeth Llc |
Oxazolo-naphthyl acids
|
WO2006060456A2
(en)
*
|
2004-11-30 |
2006-06-08 |
Plexxikon, Inc. |
Indole derivatives for use as ppar ppar active compounds
|
EP1833787A2
(en)
*
|
2004-11-30 |
2007-09-19 |
Plexxikon, Inc. |
Indole derivatives for use as ppar active compounds
|
WO2006069196A1
(en)
*
|
2004-12-21 |
2006-06-29 |
Abbott Laboratories |
3-cycloalkylcarbonyl indoles as cannabinoid receptor ligands
|
US7456289B2
(en)
*
|
2004-12-31 |
2008-11-25 |
National Health Research Institutes |
Anti-tumor compounds
|
AU2006279496A1
(en)
*
|
2005-08-17 |
2007-02-22 |
Wyeth |
Substituted indoles and use thereof
|
KR20080047591A
(ko)
*
|
2005-09-07 |
2008-05-29 |
플렉시콘, 인코퍼레이티드 |
Ppar 조절인자로서 사용하기 위한 1,3-이치환된 인돌유도체
|
EP2024349B1
(en)
*
|
2006-05-31 |
2017-08-02 |
AbbVie Inc. |
Compounds as cannabinoid receptor ligands and uses thereof
|
US8841334B2
(en)
*
|
2006-05-31 |
2014-09-23 |
Abbvie Inc. |
Compounds as cannabinoid receptor ligands and uses thereof
|
DK2046740T3
(da)
|
2006-07-22 |
2012-08-20 |
Oxagen Ltd |
Forbindelser med CRTH2-antagonistisk virkning
|
PE20090159A1
(es)
*
|
2007-03-08 |
2009-02-21 |
Plexxikon Inc |
COMPUESTOS DERIVADOS DE ACIDO INDOL-PROPIONICO COMO MODULADORES PPARs
|
EP2142522A1
(en)
|
2007-03-28 |
2010-01-13 |
Abbott Laboratories |
1, 3-thiazol-2 (3h) -ylidene compounds as cannabinoid receptor ligands
|
US7872033B2
(en)
*
|
2007-04-17 |
2011-01-18 |
Abbott Laboratories |
Compounds as cannabinoid receptor ligands
|
JP2010527929A
(ja)
*
|
2007-05-18 |
2010-08-19 |
アボット・ラボラトリーズ |
カンナビノイド受容体リガンドとしての新規な化合物
|
US9193713B2
(en)
*
|
2007-10-12 |
2015-11-24 |
Abbvie Inc. |
Compounds as cannabinoid receptor ligands
|
US7750027B2
(en)
*
|
2008-01-18 |
2010-07-06 |
Oxagen Limited |
Compounds having CRTH2 antagonist activity
|
WO2009090414A1
(en)
|
2008-01-18 |
2009-07-23 |
Oxagen Limited |
Compounds having crth2 antagonist activity
|
JP2011509990A
(ja)
*
|
2008-01-22 |
2011-03-31 |
オキサジェン リミテッド |
Crth2アンタゴニスト活性を有する化合物
|
EP2240444A1
(en)
*
|
2008-01-22 |
2010-10-20 |
Oxagen Limited |
Compounds having crth2 antagonist activity
|
GB2457040A
(en)
*
|
2008-01-30 |
2009-08-05 |
Oxagen Ltd |
1-Acetic acid indole derivatives with PGD2 activity
|
US8846730B2
(en)
*
|
2008-09-08 |
2014-09-30 |
Abbvie Inc. |
Compounds as cannabinoid receptor ligands
|
PE20110804A1
(es)
*
|
2008-09-16 |
2011-11-30 |
Abbott Lab |
Compuestos novedosos como ligandos de receptores de cannabinoides
|
PA8854001A1
(es)
*
|
2008-12-16 |
2010-07-27 |
Abbott Lab |
Compuestos novedosos como ligandos de receptores de canabinoides
|
CN103086943B
(zh)
*
|
2011-11-04 |
2015-04-15 |
山东亨利医药科技有限责任公司 |
作为crth2受体拮抗剂的吲哚类衍生物
|
US8715529B1
(en)
|
2012-01-23 |
2014-05-06 |
Arrowhead Center, Inc. |
Synthesis and applications of triazaborolopyridinium compounds and substituted triazaborolopyridinium compounds and methods of use
|
GB201322273D0
(en)
|
2013-12-17 |
2014-01-29 |
Atopix Therapeutics Ltd |
Process
|
GB201407807D0
(en)
|
2014-05-02 |
2014-06-18 |
Atopix Therapeutics Ltd |
Polymorphic form
|
GB201407820D0
(en)
|
2014-05-02 |
2014-06-18 |
Atopix Therapeutics Ltd |
Polymorphic form
|